Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of DWP-450 (Jeuveau) in Glabellar Lines
NCT02428608Phase 2Completed
- Sponsor
- Evolus, Inc.
- Start
- May 2015
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of prabotulinumtoxinA in glabellar lines, sponsored by Evolus, Inc.. Started May 2015; status: completed.
02
Drugs
prabotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT02428608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02428608.